AbbVie (NYSE: ABBV) today reported its second-quarter financial results for the period ended June 30, 2021. Net revenues increased 34% to $13.9
AbbVie (ABBV) Earnings: Key financials and quarterly highlights
Categories
biopharma
Infographic: Highlights of Gilead Sciences (GILD) Q2 earnings report
Biopharmaceutical company Gilead Sciences Inc (NASDAQ: GILD) reported its second-quarter 2021 earnings today after the closing bell. The revenue increased by 21%
IPO Alert: What to look for when Ocean Biomedical goes public
After tech start-ups, the biotechnology industry is keeping the IPO market busy nowadays. It is estimated that Wall Street is headed for
Aerovate Therapeutics IPO: What awaits the biotech firm after market debut?
The IPO market has continued the bull run so far this year, unfazed by the virus-related uncertainties, with the technology and pharma
Context Therapeutics: Another clinical-stage oncology research firm to go public soon
The US primary markets seem to be having a record-breaking start to the year, with over $171 billion raised in the first
Moderna, Inc. (MRNA) Q1 2021 Earnings Call
Moderna, Inc. (NASDAQ: MRNA) Q1 2021 earnings call dated May. 06, 2021 Corporate Participants: Lavina Talukdar — Senior Vice President and Head of Investor Relations
Veru Inc. (VERU): Q1 2021 Earnings Snapshot
Veru Inc. (NASDAQ: VERU) reported its financial results for the second quarter ended March 31, 2021, on Wednesday before the market opens.
Moderna, Inc. (MRNA) Q1 2021 Earnings Call Transcript
Moderna, Inc. (NASDAQ: MRNA) Q1 2021 earnings call dated May. 06, 2021 Corporate Participants: Lavina Talukdar -- Senior Vice President and Head of Investor
AbbVie (ABBV) Earnings: Key financials and quarterly highlights
AbbVie (NYSE: ABBV) today reported its first quarter financial results for the period ended March 31, 2021. Net income for the first
Infographic: Highlights of Gilead Sciences (GILD) Q1 earnings report
Biopharmaceutical company Gilead Sciences Inc (NASDAQ: GILD) reported its first-quarter 2021 earnings today after the closing bell. The revenue increased by 16%
Amgen Inc. (AMGN) Q1 2021 Earnings Call Transcript
Amgen Inc. (NASDAQ: AMGN) Q1 2021 earnings call dated Apr. 27, 2021 Corporate Participants: Arvind Sood -- Vice President, Investor Relations Robert A. Bradway -- Chairman
Catalyst Pharmaceuticals Inc. (CPRX) Q4 2020 Earnings Call Transcript
Catalyst Pharmaceuticals Inc (NASDAQ: CPRX) Q4 2020 earnings call dated Mar. 16, 2021. Corporate Participants: Alicia Grande -- Vice President, Chief Financial
Flexion Therapeutics Inc.(FLXN) Q4 2020 Earnings Call Transcript
Flexion Therapeutics Inc (NASDAQ: FLXN) Q4 2020 Earnings Call dated Mar. 10, 2021. Corporate Participants: Scott Young -- Vice President, Corporate Communications
Strong pipeline, M&A synergies to keep Bristol Myers on growth path
Bristol Myers Squibb Company (NYSE: BMY) is thriving on its multi-pronged growth plan, based on strategic acquisitions and the promising pipeline. Recently,
Dr. Reddy’s Laboratories Ltd. (RDY) Q3 2021 Earnings Call Transcript
Dr. Reddy's Laboratories Ltd. (NYSE: RDY) Q3 2021 earnings call dated Jan. 29, 2021 Corporate Participants: Amit Agarwal -- Head of Investor Relations Parag
Abiomed, Inc. (ABMD) Q3 2021 Earnings Call Transcript
Abiomed, Inc. (NASDAQ: ABMD) Q3 2021 earnings call dated Jan. 28, 2021 Corporate Participants: Todd A. Trapp -- Vice President and Chief Financial Officer
Current focus is on scaling up capabilities: 10x Genomics CEO Serge Saxonov
10x Genomics, Inc. (NASDAQ: TXG), a pioneer in single-cell genomics, has been eliciting significant investor interest ever since it went public more
Can COVID vaccine be a panacea for Novavax’s (NVAX) growth needs?
The market has been closely following the activities of leading biopharma companies for some time, looking for updates on their COVID vaccine
Infographic: Highlights of Gilead Sciences (GILD) Q3 earnings report
Biopharmaceutical company Gilead Sciences Inc (NASDAQ: GILD) Wednesday said its third-quarter earnings increased, aided by higher revenues. The results also exceeded the
Highlights of Bristol-Myers Squibb Company (NYSE: BMY) Q2 2020 Earnings
https://www.youtube.com/watch?v=dYv_jstT8BY&t=18s Pharmaceutical firm Bristol-Myers Squibb Company (NYSE: BMY) reported second-quarter 2020 financial results on Thursday morning. The results were better than analysts’
Amarin Corporation plc (AMRN) Q2 2020 Earnings Call Transcript
Amarin Corporation plc (NASDAQ: AMRN) Q2 2020 earnings call dated Aug. 04, 2020 Corporate Participants: Elisabeth Schwartz -- Senior Director of Investor Relations John